🟢 Veraxa Biotech is trading 5.9% up in pre-market with biotech ETF XBI up 3.64%

Veraxa Biotech is trading at $1.07, up 5.94%, with broader biotech strength offering sector-level support.

• Biotech ETF XBI was up 3.64% pre-market, supporting the sector backdrop.
• No fresh company-specific announcement was identified for October 21. The latest company releases found were dated October 13 and October 7.
• The latest clinical data announcement was October 13; no evidence directly ties the gain to a new Veraxa catalyst.